BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lu J, Xie ZY, Zhu DH, Li LJ. Human menstrual blood-derived stem cells as immunoregulatory therapy in COVID-19: A case report and review of the literature. World J Clin Cases 2021; 9(7): 1705-1713 [PMID: 33728315 DOI: 10.12998/wjcc.v9.i7.1705]
URL: https://www.wjgnet.com/1007-9327/full/v9/i7/1705.htm
Number Citing Articles
1
Wenchun Qu, Zhen Wang, Erica Engelberg-Cook, Abu Bakar Siddik, Guojun Bu, Julie G. Allickson, Eva Kubrova, Arnold I. Caplan, Joshua M. Hare, Camillo Ricordi, Carl J. Pepine, Joanne Kurtzberg, Jorge M. Pascual, Jorge M. Mallea, Ricardo L. Rodriguez, Tarek Nayfeh, Samer Saadi, Elaine M. Richards, Keith March, Fred P. Sanfilippo. Effectiveness and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-AnalysisSSRN Electronic Journal 2021;  doi: 10.2139/ssrn.3924851
2
Gabriele Zanirati, Laura Provenzi, Lucas Lobraico Libermann, Sabrina Comin Bizotto, Isadora Machado Ghilardi, Daniel Rodrigo Marinowic, Ashok K. Shetty, Jaderson Costa Da Costa. Stem cell-based therapy for COVID-19 and ARDS: a systematic reviewnpj Regenerative Medicine 2021; 6(1) doi: 10.1038/s41536-021-00181-9
3
Wenchun Qu, Zhen Wang, Erica Engelberg-Cook, Dan Yan, Abu Bakar Siddik, Guojun Bu, Julie G Allickson, Eva Kubrova, Arnold I Caplan, Joshua M Hare, Camillo Ricordi, Carl J Pepine, Joanne Kurtzberg, Jorge M Pascual, Jorge M Mallea, Ricardo L Rodriguez, Tarek Nayfeh, Samer Saadi, Ravindra V Durvasula, Elaine M Richards, Keith March, Fred P Sanfilippo. Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-AnalysisStem Cells Translational Medicine 2022; 11(7): 688 doi: 10.1093/stcltm/szac032
4
Dragan Primorac, Martin Čemerin, Vid Matišić, Vilim Molnar, Marko Strbad, Lenart Girandon, Lucija Zenić, Miomir Knežević, Stephen Minger, Denis Polančec. Mesenchymal Stromal Cells: Potential Option for COVID-19 TreatmentPharmaceutics 2021; 13(9): 1481 doi: 10.3390/pharmaceutics13091481
5
Andrew Cao, Daniel Jeyaraj, Henry Liu. Co-Administration of Menstrual Blood-Derived Stem Cells and Remdesivir for the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Induced Pneumonia: A Research ProtocolUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal 2022; 6(3): 1 doi: 10.26685/urncst.319
6
Fezzeh Heidari, Reza Heidari, Mehrdad Nasrollahzadeh Sabet, Amir Ali Hamidieh, Zohreh Saltanatpour. Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe COVID-19 PatientsCurrent Stem Cell Research & Therapy 2024; 19(5): 644 doi: 10.2174/1574888X18666230417085117